- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/00 - Drugs for dermatological disorders
Patent holdings for IPC class A61P 17/00
Total number of patents in this class: 9436
10-year publication summary
|
236
|
449
|
478
|
632
|
623
|
698
|
715
|
640
|
634
|
73
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shiseido Company, Ltd. | 4194 |
117 |
| Galderma Research & Development | 377 |
79 |
| AMOREPACIFIC Corporation | 2874 |
65 |
| Osaka University | 3362 |
53 |
| Incyte Corporation | 1039 |
49 |
| Novartis AG | 10481 |
48 |
| The Regents of the University of California | 20366 |
44 |
| Daiichi Sankyo Company, Limited | 1876 |
44 |
| L' Oréal | 5674 |
43 |
| Kao Corporation | 5026 |
39 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3354 |
39 |
| Boehringer Ingelheim International GmbH | 4587 |
38 |
| ELC Management LLC | 1144 |
38 |
| Caregen Co., Ltd. | 318 |
36 |
| Mitsubishi Tanabe Pharma Corporation | 543 |
34 |
| Pierre Fabre Dermo-Cosmetique | 361 |
34 |
| Takeda Pharmaceutical Company Limited | 2712 |
33 |
| Regeneron Pharmaceuticals, Inc. | 4510 |
33 |
| Pfizer Inc. | 3376 |
32 |
| Maruho Co., Ltd. | 95 |
30 |
| Other owners | 8508 |